Dongyan Gao

921 citations
21 papers · 771 indexed · h-index 15
Topics
Liver Disease Diagnosis and Treatment (6 papers)Genomics, phytochemicals, and oxidative stress (3 papers)Sirtuins and Resveratrol in Medicine (3 papers)
Partner nations
China

In The Last Decade

Dongyan Gao

21 papers receiving 765 citations

Peers

Dongyan Gao
Comparison fields: 5 of 82
  • Molecular Biology 368
  • Epidemiology 212
  • Complementary and alternative medicine 125
  • Pharmacology 115
  • Pathology and Forensic Medicine 83
Replace Xiaohan Zhai with:
Xiaohan Zhai China
Jinyong Peng China
Xinxin Ci China
Qianmei Zhou China
Juntian Liu China
Quan Jin China
Ren‐Bo Ding Macao
Jeon‐Ok Moon South Korea
Shakir M. Saud United States
Dongyan Gao relative to Xiaohan Zhai China Xiaohan Zhai's profile →
Citations per field
00.5×1.5×2.2×
Xiaohan Zhai · 1×
Citations per year

Countries citing papers authored by Dongyan Gao

Since Specialization
Citations

This map shows the geographic impact of Dongyan Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyan Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyan Gao more than expected).

Fields of papers citing papers by Dongyan Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongyan Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyan Gao. The network helps show where Dongyan Gao may publish in the future.

Co-authorship network of co-authors of Dongyan Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Dongyan Gao. A scholar is included among the top collaborators of Dongyan Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongyan Gao. Dongyan Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 7
3 51
4 3
5 33
6 13
7 29
8 8
9 15
10 16
11 99
12 56
13 99
14 62
15 27
16 75
17 49
18 43
19
Effect of pH, vehicles and chemical enhancers on the skin permeation of loratadine
2
20 32

About Dongyan Gao

Dongyan Gao is a scholar working on Geriatrics and Gerontology, Pharmacology and Hepatology, having authored 21 papers that have together received 771 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). The work is most often cited by research in Complementary and alternative medicine (125 citations), Geriatrics and Gerontology (53 citations) and Pharmacology (115 citations). Dongyan Gao has collaborated with scholars based in China. Frequent co-authors include Jihong Yao, Xiaofeng Tian, Yan Hu, Yan Zhao, Xiaohan Zhai, Junjun Zhou, Xue Shi, Li Lv, Wei Xu and Zhenlu Li. Their work appears in journals such as Scientific Reports, Life Sciences and Pharmaceutical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026